Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic entered the weight loss conversation not through direct approval for weight management, but rather through widespread off-label use by people seeking to reduce body weight. The medication contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone controlling appetite and blood sugar. PlexusDx offers compounded semaglutide injections starting at $149 per month through licensed 503A pharmacies, delivering the same active ingredient with transparent pricing and no insurance requirements.
How Semaglutide Became a Weight Loss Medication
The journey of semaglutide from diabetes treatment to weight loss tool began when physicians and patients noticed significant weight reduction as a side effect during clinical trials. In 2021, the FDA approved semaglutide at a higher dose under the brand name Wegovy specifically for chronic weight management, validating what many had already experienced off-label. However, the original Ozempic formulation—designed for blood sugar control at lower doses—generated enormous demand as word spread about its appetite-suppressing effects. This gap between supply and demand created a shortage that prompted many people to explore compounded alternatives like those offered by PlexusDx.
The mechanism behind weight loss is rooted in how semaglutide affects your brain and stomach. This medication stimulates GLP-1 receptors, which signal fullness to your brain, slow gastric emptying (how quickly your stomach empties), and reduce hunger hormones. Clinical studies have consistently shown that people taking semaglutide lose approximately 10-15% of their body weight over one year when combined with lifestyle changes. For individuals with obesity or weight-related health conditions, this level of weight reduction can significantly improve metabolic health, reduce joint stress, and lower cardiovascular disease risk.
Off-Label Use vs. FDA-Approved Weight Loss Medications
Off-label prescribing is a standard medical practice where doctors prescribe FDA-approved medications for conditions or populations not explicitly listed in the drug's label. With semaglutide, physicians have prescribed Ozempic for weight loss even though the original indication was type 2 diabetes, while Wegovy represents the same medication at higher doses approved specifically for weight management. This distinction matters because Ozempic and Wegovy contain identical semaglutide but are marketed, dosed, and priced differently. Many patients and providers prefer compounded semaglutide options because they provide consistent dosing, transparent pricing, and access without insurance coverage requirements.
The FDA has approved semaglutide (Wegovy) and tirzepatide (Zepbound) as dedicated weight loss medications, yet these branded options remain expensive and subject to supply constraints. Compounded semaglutide from licensed 503A pharmacies offers the same pharmaceutical-grade active ingredient at a fraction of the cost—PlexusDx charges a flat $149 per month regardless of dose level, eliminating the financial barrier many face. Insurance coverage for branded weight loss drugs remains inconsistent, and out-of-pocket costs can exceed $900 monthly, making compounded alternatives a practical choice for millions seeking evidence-based therapy.
Personalized GLP-1 Treatment: Moving Beyond One-Size-Fits-All Therapy
Not every person responds identically to semaglutide or other GLP-1 medications because genetic differences influence how effectively your body's peptide pathways function. Your genes control the sensitivity of GLP-1 receptors, the function of hormones regulating satiety, and how your metabolism processes nutrients. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment), which maps 14 metabolic pathways across 49 peptides and identifies 150+ personalized insights. Key genetic variants like GLP1R rs6923761 and GIPR rs1800437 predict whether you'll respond optimally to semaglutide or whether a dual-compound approach like GLP-Squared (semaglutide plus tirzepatide) might yield better results.
Understanding your genetic profile transforms treatment from guesswork into precision medicine. Some people achieve remarkable weight loss with semaglutide alone, while others experience better appetite suppression and metabolic improvement with tirzepatide or combination therapy. The Precision Peptide Genetic Test reveals your individual peptide pathway strengths and weak points, enabling your provider to select the exact medication and approach matched to your biology. This personalized strategy reduces trial-and-error adjustments, accelerates results, and maximizes your chances of sustained weight loss success.
Cost, Access, and Practical Considerations for GLP-1 Therapy
PlexusDx eliminates common barriers to GLP-1 treatment through straightforward, inclusive pricing and nationwide availability. Compounded semaglutide injections start at $149 per month flat—your dose may need to increase, but your price won't—plus HSA and FSA accounts are eligible for payment. The company serves all 50 states without membership fees, insurance requirements, or hidden charges, making this precision therapy accessible whether you have coverage or pay out-of-pocket. Licensed 503A compounding pharmacies ensure pharmaceutical-grade quality and consistency, giving you confidence in every injection.
Beyond medication cost, successful weight loss requires sustainable lifestyle changes including balanced nutrition, regular physical activity, and behavioral modification. GLP-1 therapy works best as part of a comprehensive program that addresses eating patterns, stress, sleep quality, and exercise habits. PlexusDx provides access to the medication itself; combining this with personalized nutrition coaching, fitness guidance, and mental health support optimizes long-term outcomes. Many patients find that the appetite suppression from semaglutide or tirzepatide creates a critical window of opportunity to build healthier habits that persist even if medication use eventually stops.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is taking Ozempic off-label for weight loss safe?
Off-label prescribing of semaglutide for weight loss is a standard medical practice supported by clinical evidence. However, semaglutide is not without side effects—nausea, vomiting, and rapid dose escalation can cause complications if not managed by an experienced provider. PlexusDx pairs compounded semaglutide with clinical oversight to monitor your response, adjust doses safely, and screen for contraindications. Always work with a healthcare provider familiar with GLP-1 therapy before starting treatment.
How much weight can you lose with semaglutide?
Clinical trials show that people taking semaglutide lose approximately 10-15% of their starting body weight over 12 months when combined with lifestyle modification. Individual results vary based on adherence, diet quality, exercise consistency, and genetics—some patients achieve 20%+ weight loss while others experience 5-10% reduction. PlexusDx's Precision Peptide Genetic Test can help predict your individual response potential by analyzing your GLP-1 receptor sensitivity and metabolic pathway function.
Why choose compounded semaglutide over brand-name Ozempic or Wegovy?
Compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient at significantly lower cost—PlexusDx charges a flat $149 monthly with no insurance required, while branded versions often exceed $900 out-of-pocket. Compounded semaglutide also sidesteps supply shortages affecting branded products and offers HSA/FSA eligibility. All PlexusDx medications come from licensed compounding pharmacies meeting strict pharmaceutical standards.
What are the main side effects of semaglutide?
Common side effects include nausea, vomiting, constipation, diarrhea, and fatigue, particularly when starting or increasing doses. Most side effects are mild to moderate and improve within 2-4 weeks as your body adjusts. Serious but rare risks include pancreatitis, gallbladder problems, and thyroid effects—this is why medical supervision from PlexusDx-connected providers is essential. Always report persistent or severe symptoms immediately.
Can the Precision Peptide Genetic Test predict if semaglutide will work for me?
The Precision Peptide Genetic Test analyzes genetic variants in GLP1R, GIPR, FTO, and MC4R genes, which influence your appetite regulation, insulin sensitivity, and metabolic efficiency. Your GLP1R variant (rs6923761) specifically predicts semaglutide responsiveness, while other pathway results help determine whether dual therapy with tirzepatide might yield better results. This test transforms treatment from guesswork into personalized medicine, available for $99 as an add-on after your first month of PlexusDx therapy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What’s the Average Weight Loss on Semaglutide? Insights and Expectations
Comparing Semaglutide and Tirzepatide for Effective Weight Loss